Pan-cancer analysis reveals the prognostic and immunologic roles of cereblon and its significance for PROTAC design
Background: Cereblon (CRBN) has emerged as a vital E3 ubiquitin ligase for Proteolysis-targeting chimera (PROTAC) design. However, few studies focus on the physiological mechanism of CRBN, and more studies are needed to explore the influence of CRBN on tumorigenesis. This pan-cancer analysis aims to...
Main Authors: | Si-Han Zhang, Na Zeng, Jian-Xuan Sun, Chen-Qian Liu, Jin-Zhou Xu, Meng-Yao Xu, Ye An, Xing-Yu Zhong, Si-Yang Ma, Hao-Dong He, Qi-Dong Xia, Jia Hu, Shao-Gang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023038513 |
Similar Items
-
Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges?
by: Marcin Cieślak, et al.
Published: (2023-03-01) -
UBE2G1 governs the destruction of cereblon neomorphic substrates
by: Gang Lu, et al.
Published: (2018-09-01) -
Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
by: Grzegorz Charliński, et al.
Published: (2021-09-01) -
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
by: Carlos Costas-Insua, et al.
Published: (2024-03-01) -
Prognostic value and immunological role
of PTPN21 in pan-cancer analysis
by: Yane Yang, et al.
Published: (2023-07-01)